Design, Synthesis, And Bioactivity Of Cyclic Lipopeptide Antibiotics With Varied Polarity, Hydrophobicity, And Positive Charge Distribution
ACS INFECTIOUS DISEASES(2020)
Abstract
Twenty-three polymyxin analogs with variations at nine amino acid positions were synthesized and assessed for antimicrobial activity and renal cytotoxicity. Compounds M-2, 14, S-2, and 16 (MIC = 0.125 4 mu g/mL) had similar or stronger activities against susceptible and drug-resistant strains of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii compared to polymyxin B (MIC = 1-2 mu g/mL). Most synthesized compounds (50% cytotoxic concentration, CC50 >= 200 mu g/mL) exhibited lower cytotoxicity than polymyxin B (CC50 = 99 +/- 6 mu g/mL). Polymyxin S2 showed high plasma stability in vitro and strong efficacy in a mouse systemic infection model (ED50 = 0.9 mg/kg) against NDM-1-producing Klebsiella pneumoniae, suggesting that it is a potential candidate for drug development. The activity and cytotoxicity results indicated that the amino acids at positions 2, 3, 6, and 7 might be replaced. Effects on activity and cytotoxicity linked to changes in the number of positively charged amino acids varied among different cyclopeptide skeletons, but the underlying mechanisms are unknown.
MoreTranslated text
Key words
Gram-negative "superbugs", novel polymyxin analogs, varied positive charges, bioactivity evaluation, structure-activity relationship
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined